Comparison of Long-Term Survival of Patients with BCLC Stage B Hepatocellular Carcinoma after Liver Resection or Transarterial Chemoembolization

A Snapshot of the Effective Indications and Results of Surgery for Hepatocellular Carcinoma in Tertiary Referral Centers

(2013) Guido Torzilli et al.   ANNALS OF SURGERY

Is Serum Alpha-Fetoprotein Useful for Predicting Recurrence and Mortality Specific to Hepatocellular Carcinoma After Hepatectomy? A Test Based on Propensity Scores and Competing Risks Analysis

(2012) Ju Hyun Shim et al.   ANNALS OF SURGICAL ONCOLOGY

Alpha-fetoprotein has no prognostic role in small hepatocellular carcinoma identified during surveillance in compensated cirrhosis

(2012) Edoardo G. Giannini et al.   HEPATOLOGY

Surgical resection for advanced hepatocellular carcinoma according to Barcelona Clinic Liver Cancer (BCLC) staging

(2012) Tian Yang et al.   JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY

Liver resection for complicated hepatocellular carcinoma: Challenges but opportunity for long-term survivals

(2012) Jen-Fu Huang et al.   JOURNAL OF SURGICAL ONCOLOGY

Hepatocellular carcinoma

(2012) Alejandro Forner et al.   LANCET

Hepatic resection can provide long-term survival of patients with non–early-stage hepatocellular carcinoma: Extending the Indication for resection?

(2012) Wen-Tsan Chang et al.   SURGERY

Hepatocellular Carcinoma

(2011) Nuh N. Rahbari et al.   ANNALS OF SURGERY

Comparison of Surgical Resection and Transarterial Chemoembolization for Hepatocellular Carcinoma beyond the Milan Criteria: A Propensity Score Analysis

(2011) Chia-Yang Hsu et al.   ANNALS OF SURGICAL ONCOLOGY

Cancer statistics, 2011

(2011) Rebecca Siegel et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Level of α-Fetoprotein Predicts Mortality Among Patients With Hepatitis C–Related Hepatocellular Carcinoma

(2011) Gia L. Tyson et al.   Clinical Gastroenterology and Hepatology

Serum alpha-fetoprotein response can predict prognosis in hepatocellular carcinoma patients undergoing radiofrequency ablation therapy

(2011) W.-Y. Kao et al.   CLINICAL RADIOLOGY

Changes in Serum Levels of HBV DNA and Alanine Aminotransferase Determine Risk for Hepatocellular Carcinoma

(2011) Chuen–Fei Chen et al.   GASTROENTEROLOGY

Management of hepatocellular carcinoma: An update

(2011) Jordi Bruix et al.   HEPATOLOGY

Outcomes of hepatic resection for huge hepatocellular carcinoma (≥10 cm in diameter)

(2011) Yo-ichi Yamashita et al.   JOURNAL OF SURGICAL ONCOLOGY

Early Decrease in α-Fetoprotein, but Not Des-γ-Carboxy Prothrombin, Predicts Sorafenib Efficacy in Patients with Advanced Hepatocellular Carcinoma

(2011) Teiji Kuzuya et al.   ONCOLOGY

Health-related quality of life in patients with hepatocellular carcinoma after hepatic resection, transcatheter arterial chemoembolization, radiofrequency ablation or no treatment

(2011) Adriana Toro et al.   SURGICAL ONCOLOGY-OXFORD

Evolving strategies for the management of intermediate-stage hepatocellular carcinoma: Available evidence and expert opinion on the use of transarterial chemoembolization

(2010) J.-L. Raoul et al.   CANCER TREATMENT REVIEWS

Survival Rates Are Comparable After Radiofrequency Ablation or Surgery in Patients With Small Hepatocellular Carcinomas

(2010) Hung–Hsu Hung et al.   Clinical Gastroenterology and Hepatology

Treatment of Intermediate/Advanced Hepatocellular Carcinoma in the Clinic: How Can Outcomes Be Improved?

(2010) R. Lencioni et al.   ONCOLOGIST

Current Strategy for Staging and Treatment: The BCLC Update and Future Prospects

(2010) Alejandro Forner et al.   SEMINARS IN LIVER DISEASE

Comparing Hepatic Resection and Transarterial Chemoembolization for Barcelona Clinic Liver Cancer (BCLC) Stage B Hepatocellular Carcinoma: Change for Treatment of Choice?

(2010) Chin-Ta Lin et al.   WORLD JOURNAL OF SURGERY

Liver Resection Improves the Survival of Patients with Multiple Hepatocellular Carcinomas

(2009) Ming-Chih Ho et al.   ANNALS OF SURGICAL ONCOLOGY

Is Liver Resection Justified in Advanced Hepatocellular Carcinoma? Results of an Observational Study in 464 Patients

(2009) Andrea Ruzzenente et al.   JOURNAL OF GASTROINTESTINAL SURGERY

Hepatic resection for hepatocellular carcinoma exceeding Milan criteria

(2009) Spiros G. Delis et al.   SURGICAL ONCOLOGY-OXFORD

Validation of the BCLC Prognostic System in Surgical Hepatocellular Cancer Patients

(2009) A. Vitale et al.   TRANSPLANTATION PROCEEDINGS

Treatment of Large and Advanced Hepatocellular Carcinoma

(2008) Eddie K. Abdalla et al.   ANNALS OF SURGICAL ONCOLOGY

Hepatectomy for Stage B and Stage C Hepatocellular Carcinoma in the Barcelona Clinic Liver Cancer Classification

(2008) Guido Torzilli   ARCHIVES OF SURGERY

The efficacy of treatment schedules according to Barcelona Clinic Liver Cancer staging for hepatocellular carcinoma – Survival analysis of 3892 patients

(2008) Jing-Houng Wang et al.   EUROPEAN JOURNAL OF CANCER

Neither Multiple Tumors Nor Portal Hypertension Are Surgical Contraindications for Hepatocellular Carcinoma

(2008) Takeaki Ishizawa et al.   GASTROENTEROLOGY

Trends in mortality from hepatocellular carcinoma in Europe, 1980‐2004

(2008) Cristina Bosetti et al.   HEPATOLOGY

Design and Endpoints of Clinical Trials in Hepatocellular Carcinoma

(2008) Josep M. Llovet et al.   JNCI-Journal of the National Cancer Institute